| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701611 | Journal of Thoracic Oncology | 2017 | 23 Pages |
Abstract
These data indicate that KMT2D is one of the major mutated genes in SCLC, and they point to perturbation of transcriptional enhancer control as potentially contributing to SCLC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Arnaud PhD, Qing MS, Breanna BS, Min MD, PhD, Xiaofei PhD, Gary PhD, Afshin MD, David PhD,